Edition:
India

Concert Pharmaceuticals Reports Q3 2018 Financial Results


Thursday, 1 Nov 2018 

Nov 1 (Reuters) - Concert Pharmaceuticals Inc ::CONCERT PHARMACEUTICALS REPORTS THIRD QUARTER 2018 FINANCIAL RESULTS AND PROVIDES COMPANY UPDATE.Q3 LOSS PER SHARE $0.74.Q3 EARNINGS PER SHARE VIEW $-0.63 -- THOMSON REUTERS I/B/E/S. 

Company Quote

9.71
-0.27 -2.71%
23 Aug 2019